Background: |
Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Implicated in Notch signaling cross-over. |
Applications: |
WB, IHC |
Name of antibody: |
TP53 (Phospho-Ser6) |
Immunogen: |
Synthetic peptide of human TP53 (Phospho-Ser6) |
Full name: |
tumor protein p53 (Phospho-Ser6) |
Synonyms: |
P53; BCC7; LFS1; TRP53 |
SwissProt: |
P04637 |
IHC positive control: |
Human breast carcinoma |
IHC Recommend dilution: |
50-100 |
WB Predicted band size: |
44 kDa |
WB Positive control: |
HT29 and Hela cells treated with UV |
WB Recommended dilution: |
500-1000 |